You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SOLTI

Showing 1 - 25 of 41
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Liquid Biopsy Genomic Profiling on Treatment Metastatic Prostate

Recruiting
  • Metastatic Prostate Cancer
  • Liquid Biopsy
  • Archival Tumor DNA sequencing
  • Barcelona, Spain
    SOLTI Cancer Research Group
May 22, 2023

Breast Cancer, HER2-negative Breast Cancer, Hormone Receptor Positive Tumor Trial (Elacestrant, Triptorelin)

Not yet recruiting
  • Breast Cancer
  • +3 more
  • (no location specified)
Aug 4, 2023

Triple-negative Breast Cancer Trial (Pembrolizumab 25 mg/ml, Paclitaxel injection)

Not yet recruiting
  • Triple-negative Breast Cancer
  • Pembrolizumab 25 mg/ml
  • Paclitaxel injection
  • (no location specified)
Oct 11, 2023

ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer, a Germline or Somatic BRCA Mutation, or a

Recruiting
  • ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer
  • a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI Status
  • Montpellier, France
  • +1 more
Nov 16, 2022

Metastatic Triple-Negative Breast Carcinoma Trial in Barcelona, Madrid, Pamplona (PD1+ TILs (NUMARZU-001) product infusion)

Not yet recruiting
  • Metastatic Triple-Negative Breast Carcinoma
  • PD1+ TILs (NUMARZU-001) product infusion
  • Barcelona, Spain
  • +3 more
Jul 8, 2022

HER2-positive Breast Cancer, Stage I Breast Cancer Trial in Barcelona (Trastuzumab and pertuzumab Subcutaneous Fixed-Dose

Recruiting
  • HER2-positive Breast Cancer
  • Stage I Breast Cancer
  • Trastuzumab and pertuzumab Subcutaneous Fixed-Dose Combination
  • Barcelona, Spain
    Hospital Clinic de Barcelona
Jan 23, 2022

Using Comprehensive Genomic Data on Next Treatment Decision

Active, not recruiting
  • Metastatic Breast Cancer
  • blood sample collection and collection of tumor tissue block
  • Barcelona, Please Select, Spain
    Translational Genomics and Targeted Therapeutics in Solid Tumour
Oct 24, 2022

Metastatic Cancer Trial in Spain (Tumor and Blood sample collection)

Recruiting
  • Metastatic Cancer
  • Tumor and Blood sample collection
  • Badalona, Barcelona, Spain
  • +14 more
Jan 23, 2023

Breast Cancer Trial (Patritumab deruxtecan, Chemotherapy, Letrozole)

Recruiting
  • Breast Cancer
  • Patritumab deruxtecan
  • +2 more
  • Barcelona, Spain
    Hospital Clinic de Barcelona
Nov 28, 2022

Breast Cancer Trial in Barcelona, Madrid, Valencia (Talimogene laherparepvec, Atezolizumab)

Active, not recruiting
  • Breast Cancer
  • Barcelona, Spain
  • +3 more
Sep 27, 2022

Breast Cancer, Hormone Receptor Positive Breast Carcinoma Trial in Badalona, Sant Cugat Del Vallès, Barcelona (Elacestrant)

Completed
  • Breast Cancer
  • Hormone Receptor Positive Breast Carcinoma
  • Badalona, Barcelona, Spain
  • +3 more
Oct 25, 2022

Metastatic Breast Cancer Trial in Portugal, Spain (Ribociclib + Letrozole OR Fulvestrant, Palbociclib + Letrozole OR

Recruiting
  • Metastatic Breast Cancer
  • Ribociclib + Letrozole OR Fulvestrant
  • +2 more
  • Creixomil, Portugal
  • +44 more
Apr 1, 2022

MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

Active, not recruiting
  • MSI-H Colorectal Cancer
  • +30 more
  • Badalona, Barcelona, Spain
  • +9 more
Oct 24, 2022

Metastatic Breast Cancer Trial in Spain (Palbociclib, Trastuzumab, Endocrine therapy)

Recruiting
  • Metastatic Breast Cancer
  • Badalona, Barcelona, Spain
  • +34 more
Oct 24, 2022

Breast Cancer Trial in Barcelona, Lleida, Tarragona (Onapristone)

Completed
  • Breast Cancer
  • Barcelona, Spain
  • +3 more
Mar 31, 2022

Breast Cancer Trial in Spain (U3 1402)

Recruiting
  • Breast Cancer
  • U3 1402
  • Badalona, Barcelona, Spain
  • +9 more
Apr 1, 2022

HER2-negative Breast Cancer, Metastatic Breast Cancer, Triple Negative Breast Cancer Trial in Spain (Olaparib)

Recruiting
  • HER2-negative Breast Cancer
  • +2 more
  • Barcelona, Spain
  • +4 more
Apr 14, 2022

Breast Cancer Trial in Spain (Atezolizumab + Trastuzumab + Vinorelbine)

Recruiting
  • Breast Cancer
  • Atezolizumab + Trastuzumab + Vinorelbine
  • Granada, Andalucía, Spain
  • +14 more
Mar 2, 2022

Breast Cancer Stage II Trial in France, Portugal, Spain (Ribociclib (neoadjuvant), Chemotherapy (adjuvant), Ribociclib

Recruiting
  • Breast Cancer Stage II
  • Ribociclib (neoadjuvant)
  • +2 more
  • Avignon, France
  • +49 more
Jul 7, 2022

Metastatic Breast Cancer Trial in Spain (Pembrolizumab, Paclitaxel)

Active, not recruiting
  • Metastatic Breast Cancer
  • Hospitalet de Llobregat, Barcelona, Spain
  • +6 more
Jan 23, 2023

HER2-positive Newly Diagnosed, Primary Breast Cancer Trial in Worldwide (BKM120, Trastuzumab, Paclitaxel)

Completed
Has Results
  • HER2-positive Newly Diagnosed, Primary Breast Cancer
  • Parkville, Victoria, Australia
  • +6 more
Oct 24, 2019

Metastatic Breast Cancer Trial in Spain (Ipatasertib, Trastuzumab, Pertuzumab)

Recruiting
  • Metastatic Breast Cancer
  • Badalona, Barcelona, Spain
  • +9 more
Oct 24, 2022

Breast Cancer Trial in Portugal, Spain (Neratinib + endocrine therapy)

Recruiting
  • Breast Cancer
  • Neratinib + endocrine therapy
  • Lisboa, Portugal
  • +14 more
Jul 23, 2021

SOLTI Breast Cancer Molecular Screening Program (AGATA)

Completed
  • Metastatic Breast Cancer
  • Biopsy
  • Hospitalet de Llobregat, Barcelona, Spain
  • +9 more
Jan 8, 2019

HER-2 Positive Breast Cancer, Estrogen Receptor Positive Breast Cancer Trial in Worldwide (palbociclib, trastuzumab, pertuzumab)

Active, not recruiting
  • HER-2 Positive Breast Cancer
  • Estrogen Receptor Positive Breast Cancer
  • San Francisco, California
  • +106 more
Mar 16, 2022